Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience

被引：0
|
作者：
Monzo, L. [1 ]
Cicogna, F. [2 ]
Tota, C. [2 ]
Petronilli, V. [2 ]
Mennuni, S. [2 ]
De Ruvo, E. [2 ]
Calo, L. [2 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Polyclin Casilino Rome, Dept Cardiol, Rome, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [41] Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real-world study in Taiwan
    Chang, Po-Cheng
    Wang, Chun-Li
    Hsiao, Fu-Chih
    Wen, Ming-Shien
    Huang, Chien-Ying
    Chou, Chung-Chuan
    Chu, Pao-Hsien
    ESC HEART FAILURE, 2020, 7 (05): : 3003 - 3012
  • [42] SACUBITRIL/VALSARTAN REAL-WORLD PERSISTENCE USING A COHORT OF HEART FAILURE PATIENTS FROM THE PRESCRIPTION & MONITORING OF SACUBITRIL/VALSARTAN STUDY (PRIME 2 STUDY)
    Teixeira Rodrigues, A.
    Murteira, R.
    Bulhosa, C.
    Cary, M.
    Guerreiro, J.
    Laires, P. A.
    Afonso-Silva, M.
    VALUE IN HEALTH, 2020, 23 : S505 - S505
  • [43] IMPACT OF SACUBITRIL/VALSARTAN ON CLINICAL OUTCOMES IN HEART FAILURE USING REAL-WORLD DATA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rahhal, Alaa
    Kasem, Mohamed
    Orabi, Bassant
    Abuyousef, Safae
    Hamou, Fatima
    Mahfouz, Ahmed
    Alyafei, Sumaya
    Hassan, Emad Ahmed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 420 - 420
  • [44] Real world experience of sacubitril/valsartan: insights on tolerability and outcome from a specialised heart failure clinic
    Neoh, K. C.
    Rasoul, D.
    Hunt, F.
    Chong, D. W. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2156 - 2156
  • [45] Real-World Experience Of Sacubitril-Valsartan Combination For Heart Failure With Reduced Ejection Fraction (HFrEF): A Study From A Heart Failure Clinic In The West Of Ireland
    Donnellan, F.
    Buckley, A.
    Moran, H.
    O'Connor, T.
    Lavin, F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S47 - S47
  • [46] Eligibility for sacubitril-valsartan in patients with acute decompensated heart failure
    Carballo, David
    Stirnemann, Jerome
    Garin, Nicolas
    Marti, Chistophe
    Serratrice, Jacques
    Carballo, Sebastian
    ESC HEART FAILURE, 2020, 7 (03): : 1282 - 1290
  • [47] Impact of Sacubitril/Valsartan on Right Heart Failure
    Imamura, Teruhiko
    Hori, Masakazu
    Ueno, Hiroshi
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2021, 62 (04) : 932 - 934
  • [48] Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study
    Haddad, Haissam
    Bergeron, Sebastien
    Ignaszewski, Andrew
    Searles, Gregory
    Rochdi, Driss
    Dhage, Priyanka
    Bastien, Natacha
    CJC OPEN, 2020, 2 (05) : 344 - 353
  • [49] Use of sacubitril/valsartan in patients with heart failure: evidence from the real world
    Valladales-Restrepo, Luis Fernando
    Sanchez-Ramirez, Nicolas
    Usma-Valencia, Andres Felipe
    Velasquez-Quirama, Santiago
    Henao-Martinez, Manuela
    Castro-Rodriguez, Jorge Alejandro
    Gaviria-Mendoza, Andres
    Machado-Duque, Manuel Enrique
    Machado-Alba, Jorge Enrique
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2211 - 2219
  • [50] Evaluating Patients With Heart Failure to Determine Eligibility for Sacubitril/Valsartan.
    Han, Jamie
    Nguyen, Quyen
    Chung, Francisco
    Mody, Freny
    Lie, J.
    Jackevicius, Cynthia
    CIRCULATION, 2018, 138
12345